G. Ferranti
University of Rome Tor Vergata
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by G. Ferranti.
Journal of The European Academy of Dermatology and Venereology | 2000
Anna Maria Carrozzo; Stefano Gatti; G. Ferranti; Grazia Primavera; Andrea Paro Vidolin; Gabriele Nini
Gougerot–Carteaud syndrome or confluent and reticulated papillomatosis (CRP), was first described by Gougerot and Carteaud as dermatosis. 1,2 It is generally considered a rare condition. The eruption consists confluent, flat, brown papules localized primarily to the intermammary and interscapular regions with subsequent spread to the breast and abdomen; at the periphery, the papules spread out forming a pigmented reticulated pattern. At present, the aetiology of CRP remains unknown. The two prominent theories are an abnormal host response to fungi 3 and a keratinization defect. 4,5 Other hypothesis include photosensitivity, 6 genetic factor, 7 amylodosis cutis 8 and endocrinopathy. 9
International Journal of Dermatology | 1997
Pietro Puddu; Giuseppe Cianchini; L. Colonna; C. R. Girardelli; G. Ferranti; Ornella De Pità
A 43‐year‐old woman was examined in October 1993 for a widespread, large, ulceronecrotic skin eruption with exception of the mucosa (Fig. 1). The skin lesions were round and regular, varied in size from 0.5 to 2 cm, and were partially covered by a brownish‐black crust. The patient had a fever ranging from 38 to 40 °C, always preceded by shivering.
Journal of The American Academy of Dermatology | 1999
Pietro Puddu; G. Ferranti; Alessandra Frezzolini; L. Colonna; Giuseppe Cianchini
We describe the clinical and laboratory findings of a young man with mycosis fungoides. The disease was associated, since the early stages, with autoimmune purpura. Interferon alfa (IFN-alpha) administration improved this patients condition, both the purpuric eruption and patchy cutaneous lesions, thus suggesting T-cell abnormalities may be responsible for the development of the disease.
Journal of The European Academy of Dermatology and Venereology | 1997
Massimo Papi; Biagio Didona; Ornella De Pità; Lorena Silvestri; G. Ferranti; Mary Gantcheva; Luca Massimo Chinni
Objectives To investigate clinical, serologic, histopathologic and immunopathologic markers of PURPLE (painful purpuric ulcers with reticular pattern of lower extremities) or atrophie blanche. Design Twelve consecutive patients affected with idiopathic PURPLE were studied in the period 1992–1996. Patients with systemic diseases correlated to PURPLE were excluded from the study. Subjects All twelve patients were hospitalized at the Istituto Dermopatico Immacolata in Rome. Results Various and dishomogeneous immunological alterations were detected. Circulating immune complexes, increased serum levels of anticardiolipin and antinuclear antibodies, reduced serum complement levels, and deposition of immunoreactants in dermal vessels, were found in a limited number of patients. The results were not statistically significant. All the patients showed very similar histopathological aspects, characterized by microvascular thromboses, endothelial swelling and segmental hyalinization of small dermal vessels. Conclusion PURPLE is a thrombogenic vasculopathy in which unspecified immunological and laboratory changes are present. The recently suggested pathogenetic role of anticardiolipin and protein C deficiency in the disorder is not confirmed by this study.
Journal of Dermatological Science | 1998
S. Barduagni; A. Frezzolini; G. Ferranti; Massimo Papi; O. De Pità
Apoptosis is a biochemically and morphologically gene-regulated distinctive form of cell death playing a pivotal role in tissue homeostatic, viral infections and clearance of damaged cells. The process is initiated by a cascade of intercellular and intracellular signals through an intrinsic cell suicide program resulting in early DNA fragmentation characterized by nuclear and cytoplasmic condensation. Recently some authors have reported apoptosis to occur in several inflammatory skin diseases, such as lichenoid reactions and cutaneous lymphomas. The aim of our study is to investigate the apoptotic phenomenon in two different forms of cutaneous necrotizing vasculitis (CNV) affecting the postcapillary venules such as leukocytoclastic and lymphocytic cutaneous vasculitis. For this purpose, the in situ nick end labelling of fragmented DNA technique has been performed on lesional skin biopsies from patients with acute phase of the disease. In both leukocytoclastic and lymphocytic forms apoptotic bodies were detected, evidencing two different characteristic patterns of distribution, probably related to the different nature of cellular inflammatory infiltrate. Our results seem to account for the involvement of apoptotic phenomena in cutaneous vasculitis; furthermore, the evaluation of in situ DNA fragmentation could be a useful tool to discriminate different forms of the disease.
European Journal of Dermatology | 2002
Alessandra Frezzolini; Patrizia Teofoli; Giuseppe Cianchini; Silvia Barduagni; M. Ruffelli; G. Ferranti; Pietro Puddu; Ornella De Pità
European Journal of Dermatology | 2002
Patrizia Teofoli; Claudio Barbieri; Sabatino Pallotta; G. Ferranti; Pietro Puddu
Archive | 1999
M. Matucci Cerinic; A. Lombardi; M. Cagnoni; G. Ferranti; O. De Pità
Journal of The European Academy of Dermatology and Venereology | 1998
Patrizia Teofoli; O. De Pità; A. Frezzolini; G. Ferranti; Pietro Puddu; M. Ribuffo
Journal of The European Academy of Dermatology and Venereology | 1998
Pietro Puddu; Giuseppe Cianchini; L. Colonna; E. Scala; G. Ferranti; G. Puddu; R. Bono; C.R. Girardelli